TY - JOUR
T1 - Synovitis biomarkers
T2 - ex vivo characterization of three biomarkers for identification of inflammatory osteoarthritis
AU - Kjelgaard-Petersen, Cecilie Freja
AU - Siebuhr, Anne Sofie
AU - Christiansen, Thorbjorn
AU - Ladel, Christoph
AU - Karsdal, Morten
AU - Bay-Jensen, Anne-Christine
PY - 2016
Y1 - 2016
N2 - Objective: Characterize biomarkers measuring extracellular matrix turnover of inflamed osteoarthritis synovium. Methods: Human primary fibroblast-like synoviocytes and synovial membrane explants (SMEs) treated with various cytokines and growth factors were assessed by C1M, C3M, and acMMP3 in the conditioned medium. Results: TNF alpha significantly increased C1M up to seven-fold (p = 0.0002), C3M up to 24-fold (p = 0.0011), and acMMP3 up to 14-fold (p <0.0001) in SMEs. IL-1β also significantly increased C1M up to five-fold (p = 0.00094), C3M four-fold (p = 0.007), and acMMP3 18-fold (p <0.0001) in SMEs. Conclusion: The biomarkers C1M, C3M, and acMMP-3 were synovitis biomarkers ex vivo and provide a translational tool together with the SME model.
AB - Objective: Characterize biomarkers measuring extracellular matrix turnover of inflamed osteoarthritis synovium. Methods: Human primary fibroblast-like synoviocytes and synovial membrane explants (SMEs) treated with various cytokines and growth factors were assessed by C1M, C3M, and acMMP3 in the conditioned medium. Results: TNF alpha significantly increased C1M up to seven-fold (p = 0.0002), C3M up to 24-fold (p = 0.0011), and acMMP3 up to 14-fold (p <0.0001) in SMEs. IL-1β also significantly increased C1M up to five-fold (p = 0.00094), C3M four-fold (p = 0.007), and acMMP3 18-fold (p <0.0001) in SMEs. Conclusion: The biomarkers C1M, C3M, and acMMP-3 were synovitis biomarkers ex vivo and provide a translational tool together with the SME model.
KW - Synovial membrane
KW - Personalized medicine
KW - Neo-epitope biomarkers
U2 - 10.3109/1354750X.2015.1105497
DO - 10.3109/1354750X.2015.1105497
M3 - Journal article
C2 - 26863055
SN - 1055-9965
VL - 20
SP - 547
EP - 556
JO - Cancer Epidemiology, Biomarkers & Prevention
JF - Cancer Epidemiology, Biomarkers & Prevention
IS - 8
ER -